Neidert, Marian Christoph http://orcid.org/0000-0003-2828-4706
Kowalewski, Daniel Johannes
Silginer, Manuela
Kapolou, Konstantina
Backert, Linus
Freudenmann, Lena Katharina
Peper, Janet Kerstin
Marcu, Ana
Wang, Sophie Shih-Yüng
Walz, Juliane Sarah
Wolpert, Fabian
Rammensee, Hans-Georg
Henschler, Reinhard
Lamszus, Katrin
Westphal, Manfred
Roth, Patrick
Regli, Luca
Stevanović, Stefan
Weller, Michael
Eisele, Günter
Funding for this research was provided by:
Filling-The-Gap program
Hartmann Müller-Stiftung für Medizinische Forschung
EMDO Stiftung
HSM-2
ERC grant MUTAEDITING (339842)
Article History
Received: 29 April 2017
Revised: 11 March 2018
Accepted: 12 March 2018
First Online: 20 March 2018
Compliance with ethical standards
:
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: DK is an employee and HGR is a shareholder of Immatics Biotechnologies GmbH. HGR is also shareholder of Curevac AG. MiW has received research grants from Acceleron, Actelion, Bayer, Isarna, MSD, Merck & Co, Novocure, Piqur and Roche and honoraria for lectures or advisory board participation or consulting from BMS, Celldex, Immunocellular Therapeutics, Isarna, Magforce, MSD, Merck & Co, Northwest Biotherapeutics, Novocure, Pfizer, Roche, Teva and Tocagen. FW has received travel support from Roche. PR has received honoraria from Roche, MSD, Novocure, Novartis and BMS for advisory board participation or lectures. The other authors declare no competing financial interests.